CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Endonov is developing the CUSTOMI® Arch Branched stent system to treat aortic dissection and aneurysms with a less invasive approach. This innovative medical device is designed to adapt to complex aortic arch anatomies, improving treatment options for high-risk patients.
Aortic dissection and aneurysms are the two most common life-threatening disorders affecting the aorta.
Unless they are treated immediately, they result in shock and death in 80% of cases.
However, according to Prof.
Koskas, today up to 50% of patients with a high surgical risk cannot be treated with traditional open surgery.
This implies that new and less invasive interventions are urgently needed.
This is not only a European challenge, but a global one that impacts patients worldwide.Endonov i…
ENDONOV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
